Aeterna Zentaris Announces "At-the-Market" Issuance Program |
| February 22, 2011 | February 2011 Bond Updates |
|
QUEBEC CITY, Feb. 22 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS)
(TSX: AEZ) (the "Company"), a late-stage drug development company
specialized in oncology and endocrinology, announced today that it has
filed a prospectus supplement dated February 22, 2011 to its U.S. shelf |
| View more at: http://www.prnewswire.com/news-releases/aeterna-zentaris-announces-at-the-market-issuance-program-116693004.html |
| Related News |